TY - JOUR
T1 - Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis
AU - Park, Yong Hwan
AU - Remmers, Elaine F.
AU - Lee, Wonyong
AU - Ombrello, Amanda K.
AU - Chung, Lawton K.
AU - Shilei, Zhao
AU - Stone, Deborah L.
AU - Ivanov, Maya I.
AU - Loeven, Nicole A.
AU - Barron, Karyl S.
AU - Hoffmann, Patrycja
AU - Nehrebecky, Michele
AU - Akkaya-Ulum, Yeliz Z.
AU - Sag, Erdal
AU - Balci-Peynircioglu, Banu
AU - Aksentijevich, Ivona
AU - Gül, Ahmet
AU - Rotimi, Charles N.
AU - Chen, Hua
AU - Bliska, James B.
AU - Ozen, Seza
AU - Kastner, Daniel L.
AU - Shriner, Daniel
AU - Chae, Jae Jin
N1 - Publisher Copyright:
© 2020, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by homozygous or compound heterozygous gain-of-function mutations in MEFV, which encodes pyrin, an inflammasome protein. Heterozygous carrier frequencies for multiple MEFV mutations are high in several Mediterranean populations, suggesting that they confer selective advantage. Among 2,313 Turkish people, we found extended haplotype homozygosity flanking FMF-associated mutations, indicating evolutionarily recent positive selection of FMF-associated mutations. Two pathogenic pyrin variants independently arose >1,800 years ago. Mutant pyrin interacts less avidly with Yersinia pestis virulence factor YopM than with wild-type human pyrin, thereby attenuating YopM-induced interleukin (IL)-1β suppression. Relative to healthy controls, leukocytes from patients with FMF harboring homozygous or compound heterozygous mutations and from asymptomatic heterozygous carriers released heightened IL-1β specifically in response to Y. pestis. Y. pestis-infected MefvM680I/M680I FMF knock-in mice exhibited IL-1-dependent increased survival relative to wild-type knock-in mice. Thus, FMF mutations that were positively selected in Mediterranean populations confer heightened resistance to Y. pestis.
AB - Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by homozygous or compound heterozygous gain-of-function mutations in MEFV, which encodes pyrin, an inflammasome protein. Heterozygous carrier frequencies for multiple MEFV mutations are high in several Mediterranean populations, suggesting that they confer selective advantage. Among 2,313 Turkish people, we found extended haplotype homozygosity flanking FMF-associated mutations, indicating evolutionarily recent positive selection of FMF-associated mutations. Two pathogenic pyrin variants independently arose >1,800 years ago. Mutant pyrin interacts less avidly with Yersinia pestis virulence factor YopM than with wild-type human pyrin, thereby attenuating YopM-induced interleukin (IL)-1β suppression. Relative to healthy controls, leukocytes from patients with FMF harboring homozygous or compound heterozygous mutations and from asymptomatic heterozygous carriers released heightened IL-1β specifically in response to Y. pestis. Y. pestis-infected MefvM680I/M680I FMF knock-in mice exhibited IL-1-dependent increased survival relative to wild-type knock-in mice. Thus, FMF mutations that were positively selected in Mediterranean populations confer heightened resistance to Y. pestis.
UR - https://www.scopus.com/pages/publications/85087011219
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000544172900002&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.1038/s41590-020-0705-6
DO - 10.1038/s41590-020-0705-6
M3 - Article
C2 - 32601469
AN - SCOPUS:85087011219
SN - 1529-2908
VL - 21
SP - 857
EP - 867
JO - Nature Immunology
JF - Nature Immunology
IS - 8
ER -